Oliver Barnes / Financial Times:
Life sciences group Thermo Fisher agrees to acquire PE-owned drug trial software maker Clario for $9.4B in an all-cash deal expected to close by mid-2026 — Deal for software group marks one of the biggest private equity exits of the year — Life sciences group Thermo Fisher has sealed …
Posted from: this blog via Microsoft Power Automate.